XML 76 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Stock Purchase Agreement
At-The-Market
Common Stock
Common Stock
Stock Purchase Agreement
Common Stock
At-The-Market
Additional Paid-In Capital
Additional Paid-In Capital
Stock Purchase Agreement
Additional Paid-In Capital
At-The-Market
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022       48,966,216              
Beginning balance at Dec. 31, 2022 $ 289,234     $ 5     $ 689,256     $ (4,137) $ (395,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       11,759              
Issuance of common stock upon exercise of stock options 56           56        
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (in shares)       48,730              
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (94)           (94)        
Issuances of common stock under 2020 ESPP (in shares)       20,748              
Issuance of common stock under 2020 ESPP 104           104        
Stock-based compensation 6,251           6,251        
Change in unrealized loss, net on marketable securities 1,667                 1,667  
Net loss (34,780)                   (34,780)
Other (in shares)       5,056              
Other 32           32        
Ending balance (in shares) at Mar. 31, 2023       49,052,509              
Ending balance at Mar. 31, 2023 262,470     $ 5     695,605     (2,470) (430,670)
Beginning balance (in shares) at Dec. 31, 2023       60,467,188              
Beginning balance at Dec. 31, 2023 246,114     $ 6     774,618     (127) (528,383)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock, net (in shares)         5,567,928 2,500,601          
Issuance of common stock, net   $ 20,000 $ 14,089   $ 1     $ 19,999 $ 14,089    
Issuance of common stock upon exercise of stock options (in shares)       80,936              
Issuance of common stock upon exercise of stock options 519           519        
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (in shares)       121,516              
Issuance of common stock upon vesting of restricted stock units, net of shares repurchased for tax withholding (109)           (109)        
Issuances of common stock under 2020 ESPP (in shares)       34,902              
Issuance of common stock under 2020 ESPP 84           84        
Stock-based compensation 6,215           6,215        
Change in unrealized loss, net on marketable securities (253)                 (253)  
Net loss (28,361)                   (28,361)
Other (in shares)       5,520              
Other (16)           (16)        
Ending balance (in shares) at Mar. 31, 2024       68,778,591              
Ending balance at Mar. 31, 2024 $ 258,282     $ 7     $ 815,399     $ (380) $ (556,744)